Establishment of a tRNA over-expression system in Trypanosoma brucei to study the role of post-transcriptional modifications on function. by Fill, Mary-Margaret
i 
 
 
 
 
 
Establishment of a tRNA over-expression system in Trypanosoma brucei  
to study the role of post-transcriptional modifications on function.  
 
 
 A Senior Honors Thesis 
 
 Presented in Partial Fulfillment of the Requirements for graduation 
 with research distinction in Microbiology in the undergraduate colleges 
 of The Ohio State University 
 
 by 
 
 Mary-Margaret Anne Fill 
 
 The Ohio State University 
 May 2007 
 
 Project Advisor:  Professor Juan Alfonzo, Department of Microbiology 
 
ii 
 
ABSTRACT 
 
Trypanosomatids are parasitic protozoa which infect millions of humans and 
animals across the globe every year.  The two primary types of these unicellular flagellates 
are Trypanosoma and Leishmania, and the World Health Organization estimates that 
approximately 400 million people worldwide are at substantial risk to develop infections 
caused by these pathogens. 
Trypanosomes also possess many significant biological and biochemical properties, 
and in particular the tRNAs of trypanosomatids undergo substantial in vivo chemical 
modifications. We focus on understanding how one particular set of modifications, i.e. 
adenosine to inosine changes in the anticodon, impact tRNA function. We are also 
interested on how other modifications like methylations may affect inosine formation.  
The goals of this project are two-fold: first, to construct a vector capable of 
successfully over-expressing tRNA in Trypanosoma brucei, and second, to successfully 
introduce two non-endogenous, tagged tRNAs into T. brucei in order to further analyze in 
vivo modifications.  To this end, we have engineered two distinct tRNA variants with 
mutations in the anticodon arm (Tag 22) and anticodon arm and loop (Tag 23).  These 
mutations serve as tags to differentiate them from endogenous tRNAs naturally found in T. 
brucei cells.  Prior to testing our overexpression system, the two "tagged" variants were 
analyzed for their ability to support known modification reactions in vitro. Since these 
variants are derived from a tRNA that undergoes adenosine to inosine changes in their 
anticodon in vivo, we tested and further showed that the mutations used to generate the 
iii 
variants do not interfere with this reaction in vitro. In the next phase of the project, the two 
variants will be cloned in a plasmid vector and expressed under the control of an 
endogenous T7 promoter and tetracycline (TET) operator, followed by transfection into 
Trypanosoma brucei cells. Total RNA isolated from the transfected cells will thus provide 
a measure of overexpression of our two tRNA variants. Successful completion of this 
phase of the project will allow further exploration into the in vivo posttranscriptional 
modifications of tRNAs through analysis of the tagged tRNA constructs.  By comparing 
the tagged tRNA construct to endogenous tRNAs, important modification reactions such as 
adenosine to inosine and cytidine to uridine editing can be further studied. As mentioned 
earlier, since these modifications play a vital role in the function of tRNA, their 
identification could be useful for future design of anti-trypanosomal treatments.   
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CHAPTER 1 
Overview of the Trypanosomatids 
 
1.1 Introduction 
 In the class kinetoplastida, the trypanosomatids are unicellular eukaryotes marked 
by the presence of a kinetoplast, a mass of DNA located within a single mitochondrion.  
The trypanosomatids are a group of flagellated protozoa, which cause a wide range of 
parasitic diseases, both in humans and in animals.  The three primary human infections 
caused by trypanosomatids are African Sleeping Sickness, or African Trypanosomiasis 
(causative agent Trypanosoma brucei), Chagas Disease (causative agent Trypanosoma 
cruzi) and the cutaneous, mucocutaneous and visceral forms of leishmaniasis (causative 
agent Leishmania species).  The primary regions of infection are Central and South 
America, Africa, the Mediterranean Basin, the Middle East and parts of Asia.  Each 
parasitic infection is transmitted to a human host by an insect vector indigenous to each 
particular region.  In recent years, The World Health Organization has estimated that over 
30 million people around the world are infected with these three diseases, and that over 
500 million more are at risk for infection (Table 1.1).
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Table 1.1: Analysis of the distribution and scope of human diseases caused by parasitic 
protozoa in the order Trypanosomatida.  
 
 
1.2 Historical Overview of RNA Editing and Modification  
 Beginning in the 1950’s, scientists began to make important discoveries concerning 
modified nucleosides in nucleic acids.  Hotchkiss (1948) discovered the first modified 
nucleoside in DNA, which was later identified by Wyatt (1950) as 5-methylcytosine 
(dm5C).  In 1956, Davis and Allen (1957) isolated 5-ribosyluracil, an isomer of uridine, 
later designated pseudouridine (ψ) by Cohn (1960), marking the first modified nucleosides 
identified in RNA.  Since those discoveries in the mid-20th century, numerous RNA 
modifications have been identified, and it has been established that mRNA, tRNA, rRNA 
and other small RNAs all undergo modification (Table 1.2).  The majority of RNA 
modifications occur posttranscriptionally, and many modifications have important 
biochemical properties that can affect the folding, function or interactions of 
ribonucloeosides.  However, it is also important to note, that many of the known RNA 
350 million 12 million Middle East, 
Africa, South 
America, China, 
India, and 
Mediterranean 
Basin  
Leishmania 
(variety of 
subspecies) 
Leishmaniasis 
(Visceral, 
Cutaneous and 
Mucocutaneous) 
Number At 
Risk Of 
Infection Per 
Year 
 
Number 
Currently 
Infected  
 
Primary 
Geographic 
Location 
 
Causative 
Agent 
 
Disease 
100 million 16-18 million Central and 
South America 
Trypanosoma 
cruzi 
Chagas Disease  
60 million 50,000-70,000 Africa  Trypanosoma 
brucei 
African 
Trypanosomiasis  
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modifications have no identifiable impact on cellular metabolism, leading to many 
questions concerning their purpose.     
Source RNA 
Archaea Bacteria Eukarya 
tRNA 36 42 47 
rRNA   1a 4a 
   SSU 11 8 18 
   LSU 8 14 12 
   5S 3   1 
   5.8S     5 
mRNA     13 
tmRNA   2   
snRNA     11 
Chromosomal RNA     2 
Other small RNA     1 
 
a Subunit origin not shown, or is reported in a mixture of SSU and LSU rRNAs. 
Table 1.2: Phylogenetic distribution of modified ribonucloeosides reported in RNA 
Adapted from Rosenski, et al. 1999.   
 
In 1986, Benne and collaborators discovered a surprising RNA modification in the 
mitochondrial mRNA of kinetoplastid protozoa.  They showed evidence of the addition 
and deletion of several uridine residues in the mitochondrial mRNA that were not encoded 
in the organism’s genome.  Shortly after this discovery, the conversion of cytidine to 
uridine (Powell et al. 1987; Chen et al. 1987) and the conversion of adenosine to inosine 
(Bass and Weintraub 1988; Wagner et al. 1989) were identified in human mRNA and viral 
RNAs respectively.  This sub-class of posttranscriptional modifications was later 
designated RNA editing, a term which refers to the “posttranscriptional alteration of 
sequence information in mRNA beyond what is encoded in the DNA genome from various 
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organisms” (Benne et al. 1986).  Shortly after the identification of nucleotide changes in 
mRNA, similar alterations were noted in non-coding RNA, such as tRNA, instigating a 
new assessment of the definition of RNA editing to include “any alteration in the sequence 
of an RNA (coding or non-coding) that leads to the introduction of one of the four 
canonical nucleotides” (Covello and Gray 1998).   
In addition, there have been repeated attempts to distinguish between RNA editing 
and modification, as the two have been lumped into the same category since their original 
discovery.  A more literal definition of editing has been assumed in recent years as any 
sequence alteration that changes the genetic meaning of a transcript, and modification has 
been limited only to structural change (Grosjean and Bjork 2004).   
 
1.3 Applications to tRNA 
 Transfer RNAs play a crucial role in the translation of the genetic code (as mRNA) 
into functional proteins.  However, it is important to note that tRNAs undergo an extensive 
maturation process which allows them to function at their highest potential within the cell.  
Of all of the types of RNA, the most modifications have been identified with respect to 
tRNAs.  To date, over 100 posttranscriptional modifications have been identified in 
Bacterial, Archaeal and Eukaryotic tRNA, and it is estimated that there are many more 
which are yet to be isolated.  Most of the identified modifications appear to play a role in 
tRNA structure and appear to assist in achieving accurate folding.  However, many of these 
modifications are not necessary for cell survival, leading to their classification as structural 
modulators.   
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 Although the other major type of RNA modification, RNA editing, was first 
discovered in mRNA, it has since been found in the tRNAs of many species.  Unlike many 
other modifications discussed earlier, tRNA editing is frequently essential for cell viability.  
To date, editing of tRNA has been found at many positions in the classical tRNA structure, 
including: the acceptor stem, tRNA backbone and anticodon stem and loop.  This was first 
reported in 1993 when Gray and co-workers published data supporting the addition of 
nucleotides at the acceptor stem of A. castellani tRNAs (Lonergan and Gray 1993).  
However, some of the best studied tRNA editing events are the cytidine to uridine (C to U) 
changes that occur in the tRNA backbone in various plant species (Fey et al. 2002).   
 
1.4 Applications to trypanosomatids 
 Although RNA editing was first discovered in the kinetoplastids (Benne et al. 
1986), the majority of work done on RNA editing has been in plants, animals, bacteria and 
yeast.  However, the trypanosomatids have been a source of many important scientific 
discoveries including: RNA editing, mRNA trans-splicing, Eukaryotic poly-cistronic 
transcription, and a mechanism for large-scale mitochondrial tRNA import.  The relatively 
recent discovery of C to U editing in vivo of a non-coding RNA, tRNATrp, began a period 
of intense investigation into RNA editing and modification events in trypanosomatids.  
Since then, numerous editing events have been isolated in trypanosomal tRNA, including 
cytidine to uridine (C to U) and adenosine to inosine (A to I) base changes in tRNAThr by 
hydrolytic deamination (Figure 1.1).  In 2006, Rubio and colleagues showed that C to U 
editing at position 32 of the anticodon loop stimulated A to I editing at position 34 in T. 
brucei tRNAThr (Figure 1.2).  The mechanism of inosine formation at position 34 has been 
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relatively well defined in eukaryotic systems, and it is known that the enzymes ADAT2 
and ADAT3 perform the hydrolytic deamination of adenosine.  This editing event is fairly 
common as editing at position 32 allows “wobbling” of the tRNA anticodon in order to 
recognize certain mRNA codons for which there is no complementary tRNA.  For 
example, in T. brucei, there are four codons which code for threonine: ACC, ACU, ACG 
and ACA.  However, there are only three tRNAThr, with anticodons: AGU, CGU and UGU.  
When tRNAThr (AGU) undergoes A to I editing at position 32, the inosine can effectively 
wobble to bind with the ACU mRNA codon.  Therefore this editing event is critical for 
effective translation of the ACU threonine codon in T. brucei.      
 Although in vitro assays show that ADAT2/ADAT3 enzymes can successfully 
deaminate cytidine, and a deamination motif similar to that in adenosine has been found in 
cytidine; the exact deamination mechanism of C to U has not been completely defined.         
       
 
                               
 
Figure 1.1: Mechanism of hydrolytic deamination of adenosine to inosine, and proposed 
mechanism of hydrolytic deamination of cytidine to form uridine.  The deamination 
N
N6
NH2
N
OH2
NH3
N
NH6
O
N
N
N4
NH2
O N
NH4
O
OOH2
NH3
Cytidine Uridine 
Adenosine Inosine 
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enzymes have an active site which contains a proton shuttling glutamate capable of 
forming a complex between water and zinc to create a nucleophile.  This nucleophile 
attacks at the C6 carbon in adenosine and removes an ammonia group creating inosine.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Editing events in tRNAThr (AGU): cytidine to uridine (C to U) and adenosine to 
inosine (A to I) editing.   
 
1.5 In vitro challenges  
 Although it is possible to synthetically modify and edit tRNAs, it is costly.  In 
addition, it is only possible to synthesize RNA with modifications which are available as a 
phosphoramidite.  There are undoubtedly hundreds of more chemical modifications and 
editing events which are currently unknown to scientists, yet, which play a substantial role 
in the molecular biology of the cell.  It is much more reasonable to create a system in 
which the cell’s machinery can perform all of the editing and modifications itself.  There is 
optimism that an editing pathway unique to Trypanosoma brucei could be utilized in the 
future as a target for effective anti-trypanosomal treatments.        
 
U 
I 
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CHAPTER TWO 
The Creation of a tRNA Over-Expression System in Trypanosoma brucei 
 
2.1 Introduction  
  The global effect of Trypanosoma brucei infections has been established in 
Chapter One of this thesis.  However, it is now important to assess potential targets to anti-
trypanosomal treatments.  There are many editing and modification processes present in 
vivo in T. brucei, and there is optimism that a unique editing pathway could be an excellent 
drug target.  In order to achieve that goal, it is crucial to continue to identify editing and 
modification events, to understand their mechanisms and to isolate a particular event 
specific only to Trypanosoma brucei.   
 The goals of this project were two-fold.  The first step was to create two unique 
sequence-tagged variants of T. brucei tRNAThr. These constructs would then be tested for 
in vitro A to I editing.  The second step was to construct an over-expression plasmid 
capable of creating a high concentration of these tagged tRNAs which would be edited and 
modified by T. brucei cellular machinery (Figure 2.1).   
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Figure 2.1: Schematic representing project design.   
 
2.2 Methods  
2.2.1 Creation and Testing of Tagged tRNAs  
 In order to identify and isolate modified tRNAs, two distinct tRNAThr mutant 
constructs were created with alterations made to the anticodon arm (Tag 22) and anticodon 
arm and loop (Tag 23) of tRNA threonine (AGU) (Figure 2.2).  However, it was critical 
that the sequence tags be in such a location in the tRNA as to not affect potential editing 
and modification by T. brucei machinery.   
 In order to confirm that that the sequence tags did not interfere with editing events, an 
assay was performed to measure the capability of the tagged tRNAs to undergo inosine 
formation at position 34 (Figure 2.3).  [α-32P]-ATP uniformly labeled tRNAs were 
incubated with Tb ADAT2/3 enzymes for 1 hour at 27°C.  Subsequently, the tRNAs were 
digested with Nuclease P1 to generate 5’-monophosphates, and were then separated by 
one-dimensional thin layer chromatography (TLC) and visualized by PhosphoImager 
12 
analysis.  TLC analysis showed that inosine formation at position 34 of the tagged tRNAThr 
constructs proceeded in a normal fashion, indicating that the sequence tags did not interfere 
with the mechanism of inosine formation.     
                   
 
 
 
 
  
 
 
 
 
Figure 2.2: Schematic of distinct tRNAThr (AGU) constructs with base changes highlighted 
in gray.   
 
 
                   
[tRNA]
p
I
p
A
[tRNA]
P
I
P
A
A B
 
Figure 2.3: Trypanosoma brucei tRNAThr(AGU) A) Tag22 and B) Tag 23 constructs. Lane 
1 is a no enzyme control with cold marker, and lanes 2-6 are in the presence of 
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TbADAT2/3 enzymes and increasing concentrations of tRNA (5, 10, 20, 40, 80 picomoles, 
respectively).   
 
2.2.2 Vector Selection and Evaluation 
 Although numerous vectors were evaluated for their potential use as an over-
expression system, ultimately the pLEW82 plasmid was chosen for over-expression of the 
tagged tRNAThr constructs (Figure 2.4).  The original pLEW82 plasmid contains a large 
luciferase gene region under the control of an endogenous 10% T7 promoter and 
tetracycline (TET) operator, as part of a TET “On” system.  Two T7 terminators are 
present at the end of the coding region to ensure effective termination (Figure 2.5).  Other 
advantages of the pLEW82 plasmid include multiple recognition sites for numerous 
restriction enzymes and resistance markers for ampicillin (AmpR), for selection purposes in 
Escherichia coli and phleomycin (Phleo), for selection purposes in Trypanosoma brucei.  
In addition, it was hypothesized that the regulatory mechanisms present in pLEW82 should 
be able to effectively control gene expression within the selected Trypanosoma brucei cell 
line.   
 
 
 
 
 
 
 
Figure 2.4: Schematic of the pLEW82 plasmid 
Adapted from Wirtz and Cross, 1999. 
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Figure 2.5: Schematic of the transcriptional control elements present in the pLEW82 
plasmid. 
 
 
 
 Before proceeding with cloning the tagged tRNA constructs into the selected 
plasmid, a separate assay was performed to test the effectiveness of the transcriptional 
control elements present in pLEW82.  There was some concern that T7 RNA polymerase 
would not be fully functional or achieve optimum control in a Eukaryotic system such as 
Trypanosoma brucei.  To test this, a chloramphenicol acetyltransferase (CAT) reporter 
assay was performed by cloning the CAT gene into pLEW82 and measuring 
chemiluminescence levels at varying time points throughout an acetylation assay (Figure 
2.6).  The CAT assay showed that T7 RNA polymerase was fully functional in T. brucei 
and that transcriptional control could be achieved in a tetracycline-dependent manner.    
 
 
  
TET 
Tagged 
tRNA gene 
T7 
Promoter 
TET 
Operator 
T7 
Terminators 
TET 
Repressor 
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Figure 2.6: Trypanosoma brucei cells are capable of expressing active T7 RNA 
Polymerase in a tetracycline-dependent manner.  This is demonstrated by using a 
chloramphenicol acetyltransferase (CAT) reporter assay.        
 
2.2.3 Cloning  
 In order to effectively clone the tagged tRNA constructs into a Trypanosoma brucei 
cell line, the following cloning scheme was used.  The tagged tRNAs were first ligated into 
TOPO®, then transformed into Escherichia coli DH5α competent cells, and digested with 
EcoRI restriction endonuclease to confirm the correct fragment size (Figure 2.7).  
Following completion of that phase of cloning, each tagged tRNA was ligated into 
pLEW82, transformed into Escherichia coli DH5α competent cells and digested with 
HindIII and XbaI restriction endonucleases.  After screening colonies and confirming the 
desired product size, 250 milliliters of two selected clones were midi-prepped and run 
through a QIAGEN column to extract purified plasmid DNA.      
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Figure 2.7: 1% Agarose gel confirming sizes of Tag 22 and Tag 23 tRNA constructs in 
TOPO®.   
 
 
2.2.4 Transfection 
 Following isolation of purified plasmid DNA, Trypanosoma brucei cells were 
prepped for electroporation.   
 After transfection, the T. brucei cells were recovered for a period of two to three 
weeks, allowing them sufficient time to repair from the electroporation and incorporate and 
translate the plasmid.   
 
2.2.5 Preparations for Northern Blotting 
Following the recovery period, stable transfectents were chosen to extract total 
RNA from.  The T. brucei cells were spun down, and total RNA was isolated by guanidine 
extraction techniques.  Next, the RNA was run on a denaturing acrylamide gel and the area 
where tRNAs are known to migrate was cut out and transferred to a membrane (Figure 
2.8).    
 
100    
bp 
Tag 22 Tag 23 
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Figure 2.8: 6% Acrylamide RNA gel.  Markers are loaded on either side of total RNA 
samples.   
 
 In order to perform Northern blots, a probe was constructed which would ideally 
hybridize only to its complementary sequence of either the tagged tRNAThr sequences of 
Tag 22 and Tag 23 or wild-type tRNAThr.  Initially two probes were created, WT 833R and 
TAG 834R; however a third probe was also constructed, TAG 677R (Figure 2.9).  The WT 
833R probe was designed to hybridize to wild type tRNAThr on the D loop and anticodon 
stem, whereas the TAG 834R probe was constructed to hybridize to the same region of the 
tagged tRNAThr construct.  The third probe, TAG 677R, was designed to hybridize to the 
TΨC loop, variable loop and anticodon stem of the tagged tRNAThr construct.  Each probe 
was end-labeled with Gamma 32P-ATP, and evaluated with the scintillation counter to 
achieve satisfactory radioactivity levels (normally 3.00 – 4.00 x 105 counts/ml).          
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Figure 2.9: Maps of distinct oligonucleotide probes created for hybridization to wild type 
or tagged constructs in Northern blotting.     
 
2.2.6 Northern Blotting 
 The membrane was pre-hybridized for at least 30 minutes with pre-hybridization 
(prehyb) solution (150µl per cm2 of membrane) and ssDNA (10µl per ml prehyb) at 45ºC.  
The membrane was then hybridized with prehyb solution (150µl per cm2 of membrane), 
ssDNA (10µl per ml prehyb/hyb) and end-labeled probe (106 cpm/ml of hyb) overnight at 
45ºC.  Following overnight hybridization, the hyb was saved and the membrane was 
washed with solutions 1, 1.5, 2.0 and stripping solution to achieve optimum hybridization 
of the probe to the desired tRNA (350µl wash required per cm2 of membrane).  
19 
Visualization of hybridization was achieved by using the Phospho-Imager and ImageQuant 
analysis.        
 
2.3 Discussion  
      
 
 
 
Figure 2.10: Northern blot using TAG 834R and WT 833R probes.  Lanes 1-3, Different 
concentrations of RNA isolated from Tet- T. brucei cells.  Lane 4, Tag 22 transcript.  Lanes 
5-7, Different concentrations of RNA isolated from Tet+ T. brucei cells.  Lane 8, Wild 
Type transcript.  
 
  There is strong hybridization to the Tag 22 transcript with the TAG 834R probe 
and substantial hybridization to the wild type transcript with the WT 833R probe.  
However, there is little to no significant hybridization to the Tet+ and Tet- T. brucei cell 
RNA extracts.   
 
 
 
 
 
Figure 2.11: Northern blot using TAG 677R probe.  Lanes 1-3, Different concentrations of 
Tag 22 transcript.  Lanes 4-6, Different concentrations of Wild Type transcript.   
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 Using a different oligo designed to hybridize to the TΨC loop, variable loop and 
anticodon stem of the sequence tagged tRNAThr; Tag 22 transcript and WT transcript were 
probed.  Significantly different levels of hybridization were achieved between the sequence 
tagged and wild type transcripts.   
     
                                        
Tag 23 Tag 22
Tet - Tet + Tet - Tet +
 
Figure 2.12: Northern blot using TAG 677R probe.  Lane 1, Tet-, Tag 23 cells isolated 
from T. brucei.  Lane 2, Tet+, Tag 23 cells isolated from T. brucei.  Lane 3, Tet-, Tag 22 
cells isolated from T. brucei.  Lane 4, Tet+, Tag 22 cells isolated from T. brucei.     
 
 RNA was isolated from four different T. brucei cell cultures: Tag 23, Tet-; Tag 23, 
Tet+; Tag 22, Tet-; and Tag 22, Tet+; and probed with the TAG 677R probe.  Significant 
levels of hybridization were achieved with all cell cultures, although no significant 
difference was observed between Tet+ and Tet- cultures.      
 Thus far, the work that has been completed on the over-expression plasmid has 
yielded several conclusions.  First, we can conclude that T7 RNA polymerase is fully 
functional in the Trypanosoma brucei cell line, and that the transcriptional control 
elements present in the pLEW82 plasmid effectively control transcription and in a 
tetracycline dependent manner.  Second, we can conclude that both sequence tags on the 
tRNAThr (AGU) constructs do not affect inosine formation in vitro.  We have also 
established through Northern blot analysis that the probe to the sequence tag of tRNAThr 
(AGU) is specific for the tagged tRNA constructs.   
21 
 Although the tRNAThr (AGU) over-expression vector is fully functional, further 
optimization of the current version of this vector is needed to achieve maximal over-
expression.      
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CHAPTER 3 
Conclusions and Future Work  
 
 Although many discoveries have been made in the study of RNA editing and 
modification, there is still much work to be done.  By creating large amounts of tagged 
tRNA which is edited and modified by the Trypanosoma brucei cellular machinery, there 
is optimism that more can be discovered about these editing and modification events.   
 Several substantial steps have been made in the creation of an over-expression 
vector.  It has been shown that T7 RNA polymerase is fully functional in T. brucei, and 
that transcriptional expression can be controlled in a tetracycline-dependent manner.  It has 
also been shown that the sequence tagged tRNAThr (AGU) constructs undergo normal 
adenosine to inosine formation and that the probe created for Northern blot analysis is 
specific for the tagged constructs, Tag 22 and Tag 23.   
 Although these are substantial steps toward creating the ideal over-expression 
system, there are still more optimizations which can be made to the plasmid.  We plan to 
insert an integration site into the plasmid so that the contents of the plasmid will undergo 
homologous recombination and be inserted into the T. brucei chromosome.  Other research 
has been done concerning potential replacement of the mutant 10% T7 promoter 
endogenous to pLEW82 with either a T. brucei Parp promoter or WT 100% T7 promoter 
to achieve maximum over-expression.   
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 Once optimum over-expression levels have been achieved, there are many potential 
directions to be undertaken.  Larger quantities of in vivo modified tRNAs can be isolated 
for further analysis of their chemical modifications.  These modified tRNAs may then be 
used to study editing pathways to determine specific components of the editing machinery.  
Although many of these pathways remain unknown, the underlying goal is to find novel 
editing mechanisms unique to Trypanosoma brucei as a stepping stone towards the design 
of ideal drug targets to combat disease.       
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